Epileptic Encephalopathy Clinical Trial
Official title:
Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep
This is a phase 2, double-blind study to assess the efficacy, safety, tolerability, and pharmacokinetics of NBI-827104 when administered once daily for 13 weeks in pediatric subjects with Epileptic Encephalopathy with Continuous Spike-and-Wave During Sleep (EECSWS).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01858285 -
Genetics of Epilepsy and Related Disorders
|
||
Recruiting |
NCT04802135 -
Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy
|
||
Terminated |
NCT03955432 -
Long-term Cardiac Monitoring in Epilepsy
|
N/A | |
Recruiting |
NCT05722990 -
Genetic Investigations in Children With Developmental and Epileptic Encephalopathies in Ho Chi Minh City, Vietnam
|
||
Enrolling by invitation |
NCT05301894 -
Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep
|
Phase 2 | |
Recruiting |
NCT02603991 -
Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE)
|
N/A | |
Recruiting |
NCT04496310 -
Tele-epic (Telemedicine for Epilepsy Care)
|
N/A | |
Recruiting |
NCT03934268 -
A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy
|
||
Active, not recruiting |
NCT03024827 -
Cannabidiol in Children With Refractory Epileptic Encephalopathy
|
Phase 1 | |
Active, not recruiting |
NCT03936777 -
A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome
|
Phase 3 |